Springer Seminars in Immunopathology

, Volume 17, Issue 4, pp 375–384 | Cite as

Evidence for a superantigen in the pathogenesis of tuberculosis

  • Jeffrey D. Ohmen
  • Robert L. Modlin


Internal Medicine Tuberculosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM (1992) Selective expansion of T cells expressing T cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 89:4066Google Scholar
  2. 2.
    Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, Romagne F, Malissen B, Leung DYM (1993) Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 177:791Google Scholar
  3. 3.
    Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, Greenberg AE, De Cock KM (1995) Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 345:607Google Scholar
  4. 4.
    Al-Daccak R, Mehindate K, Hebert J, Rink L, Mecheri S, Mourad W (1994) Mycoplasma arthritidisderived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line. Infect Immun 62:2409Google Scholar
  5. 5.
    Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rea TH, Modlin RL (1989) Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 142:1114Google Scholar
  6. 6.
    Barnes PF, Fong S, Brennan PJ, Twomey PE, Mazumder A, Modlin RL (1990) Local production of tumor necrosis factor and interferon-γ in tuberculous pleuritis. J Immunol 145:149Google Scholar
  7. 7.
    Bloom BR, Murray CJL (1992) Tuberculosis: commentary on a re-emergent killer. Science 257:1055Google Scholar
  8. 8.
    Bowness P, Moss PAH, Tranter H, Bell JI, McMichael AJ (1992) Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors Vβ6.9 and Vβ22. J Exp Med 176:893Google Scholar
  9. 9.
    Braunstein NS, Weber DA, Wang X, Long EO, Karp D (1992) Sequences in both class II major histocompatibility complexα andβ chains contribute to the binding of the superantigen toxic shock syndrome toxin 1. J Exp Med 175:1301Google Scholar
  10. 10.
    Carlsson R, Fischer H, Sjogren HO (1988) Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 140:2484Google Scholar
  11. 11.
    Centers for Disease Control and Prevention (1995) Estimates of future global tuberculosis morbidity and mortality. JAMA 271:739Google Scholar
  12. 12.
    Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, Marrack P, Kotzin BL (1990) Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med 172:981Google Scholar
  13. 13.
    Flynn JL, Goldstern MM, Triebold KJ, Koller B, Bloom BR (1992) Major histocompatibility complex class I-restricted T cells are required for resistance toMycobacterium tuberculosis infection. Proc Natl Acad Aci USA 89:12013Google Scholar
  14. 14.
    Herman A, Croteau G, Sekaly R, Kappler J, Marrack P (1990) HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med 172:709Google Scholar
  15. 15.
    Herman A, Labrecque N, Thibodeau J, Marrack P, Kappler JW, Sekaly RP (1991) Identification of the staphylococcal enterotoxin A superantigen binding site in theβ1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci USA 88:9954Google Scholar
  16. 16.
    Hewitt CRA, Lamb JR, Hayball J, Hill M, Owen MJ, O'hehir TE (1992) Major histocompatibility complex independent clonal T cell anergy by direct interaction ofStaphylococcus aureus enterotoxin B with the T cell antigen receptor. J Exp Med 175:1493Google Scholar
  17. 17.
    Hoffenbach A, Langlade Demoyen P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F (1989) Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 142:452Google Scholar
  18. 18.
    Hudson DR, Robinson H, Fraser JD (1993) Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor Vβ specificity. J Exp Med 177:175Google Scholar
  19. 19.
    Hurley JH, Shimonkevitz R, Hanagan A, Enney K, Boen E, Malmstrom S, Kotzin BL, Matsumura M (1995) Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J Exp Med 181:2229Google Scholar
  20. 20.
    Jardetzky TS, Brown JH, Gorga CJ, Stern LJ, Urban RG, CM Y, Stauffacher C, Strominger JL, Wiley DC (1994) Three-dimensional structure of a human class II histocompatability molecule complexed with a superantigen. Nature 368:711Google Scholar
  21. 21.
    Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF (1993) Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 148:1292Google Scholar
  22. 22.
    Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston A, Carrel S, Posnett DN, Choi Y, Marrack P (1989) Vβ-specific Stimulation of human T cells by staphylococcal toxins. Science 244:811Google Scholar
  23. 23.
    Karp DR, Long EO (1992) Identification of HLA-DR1β chain residues critical for binding staphylococcal enterotoxins A and E. J Exp Med 175:415Google Scholar
  24. 24.
    Karp DR, Teletski CL, Scholl P, Geha R, Long EO (1990) Theα1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature 346:474Google Scholar
  25. 25.
    Ladel CH, Daugelat S, Kaufmann SH (1995) Immune response toMycobacterium bovis bacille Calmette Guerin infection in major histocompatability complex class I- and class IIdeficient knockout mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol 25:377Google Scholar
  26. 26.
    Maillard J, Bloom BR (1972) Immunological adjuvants and the mechanism of cell cooperation. J Exp Med 136:185Google Scholar
  27. 27.
    Matsuyama S, Koide Y, Yoshida TO (1995) HLA class II molecule-mediated signal transduction mechanism responsible for the expression of interleukin-1β and tumor necrosis factor-α genes induced by a staphylococcal superantigen. Eur J Immunol 23:3194Google Scholar
  28. 28.
    McCormack JE, Callahan JE, Kappler J, Marrack PC (1993) Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785Google Scholar
  29. 29.
    Miethke T, Wahl C, Regele D, Gaus H, Heeg K, Wagner H (1993) Superantigen mediated shock: a cytokine release syndrome. Immunobiology 189:270Google Scholar
  30. 30.
    Mitchell IC, Turk JL, Mitchell DN (1992) Detection of mycobacterial rRNA in sarcoidosis with liquidphase hybridisation. Lancet 339:1015Google Scholar
  31. 31.
    Moller DR, Konishi K, Kirby M, Balbi B, Crystal RG (1988) Bias toward use of a specific T cell receptorβ chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest 82:1183Google Scholar
  32. 32.
    Mollick JA, McMasters RL, Grossman D, Rich RR (1993) Localization of a site on bacterial superantigens that determines T cell receptorβ chain specificity. J Exp Med 177:283Google Scholar
  33. 33.
    Panina-Bordignon P, Fu X, Lanzavecchia A, Darr RW (1992) Identification of HLA-DRα chain residues critical for binding of the toxic shock syndrome toxin superantigen. J Exp Med 176:1779Google Scholar
  34. 34.
    Posnett DN, Schmelkin DA, Burton DA, August A, McGrath H, Mayer LF (1990) T cell antigen receptor V gene usage: Increases in Vβ8+ T cells in Crohn's disease. J Clin Invest 85:1770Google Scholar
  35. 35.
    Reggiardo Z, Middlebrook G (1974) Failure of passive serum transfer of immunity against aerogenic tuberculosis in rabbits. Proc Soc Exp Biol Med 145:173Google Scholar
  36. 36.
    Russell JK, Ponzer CH, Johnson HM (1991) Bothα-helices along the major histocompatibility complex binding cleft are required for staphylococcal enterotoxin A function. Proc Natl Acad Aci USA 88:7228Google Scholar
  37. 37.
    Saboor SA, Johnson NM, McFadden J (1992) Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 339:1012Google Scholar
  38. 38.
    Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J (1992) Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 33:890Google Scholar
  39. 39.
    Stankova M, Rozsypal H, Kubin M, Slosarek M, Horova B, Bruckova M (1995) Mycobacterial infections in patients with AIDS in a low HIV prevalence area. Cent Eur J Public Health 2:100Google Scholar
  40. 40.
    Taub DD, Newcomb JR, Rogers TJ (1992) Effect of isotypic variations of MHC class II molecules on staphylococcal enterotoxin presentation to murine T cells. Cell Immunol 141:263Google Scholar
  41. 41.
    Tokman MG, Carey KD, Quimby FW (1995) The pathogenesis of experimental toxic shock syndrome: the role of interleukin-2 in the induction of hypotension and release of cytokines. Shock 3:145Google Scholar
  42. 42.
    Trede NS, Tsytsykova AV, Chatila T, Goldfeld AE, Geha RS (1995) Transcriptional activation of the human TNF-α promoter by superantigen in human monocytic cells: role of NF-κB. J Immunol 155:902Google Scholar
  43. 43.
    Uckun FM, Tuel Ahlgren L, Obuz V, Smith R, Dibirdik I, Hanson M, Langlie MC, Ledbetter JA (1991) Interleukin 7 receptor engagement stimulates tyrosine phosphorylation, inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human fetal thymocytes. Proc Natl Acad Sci USA 88:6323Google Scholar
  44. 44.
    Webb SR, Hutchinson J, Hayden K, Sprent J (1994) Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo. J Immunol 152:586Google Scholar
  45. 45.
    Zhang M, Gately MK, Wang E, Wolf SF, Lu SZ, Modlin RL, Barnes PF (1994) Interleukin-12 at the site of disease in tuberculosis. J Clin Invest 93:1733Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • Jeffrey D. Ohmen
    • 1
  • Robert L. Modlin
    • 1
    • 2
  1. 1.Division of Dermatology, Department of MedicineUCLA School of MedicineLos AngelesUSA
  2. 2.Department of Microbiology and ImmunologyUCLA School of MedicineLos AngelesUSA

Personalised recommendations